Lan Wang

Dr. Lan Wang is a biotech entrepreneur and principal investigator with three decades of experience building and advancing technologies in therapeutics, nanotechnology, and medical devices. Her work spans synthetic biocompatible nanoparticles, organ‑on‑a‑chip platforms, antimicrobial biomaterials, and photonic disinfection systems, supported by federal funding. She has held scientific and leadership roles at Paretor, Cue.coop, Novartis, FoldRx, Millennium, and BioTransplant, contributing to two approved therapies for FAC and FAP. Across multiple ventures, she combines scientific depth with product strategy to translate breakthrough technologies into clinically and commercially meaningful solutions.